Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system

by Yinghong Zhai, Xiaofei Ye, Fangyuan Hu, Jinfang Xu, Xiaojing Guo, Yonglong Zhuang, Jia He
Published 2019-11-01

Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells

by Jinfang Xu, Jun Fang, Zhonghao Cheng, Longlong Fan, Weiwei Hu, Feng Zhou, Hong Shen
Published 2018-08-01

Combined EGFR and VEGFR versus single EGFR signaling pathways inhibition therapy for NSCLC: a systematic review and meta-analysis.

by Xinji Zhang, Yesheng Li, Hui Li, Yingyi Qin, Chong Bai, Feng Xu, Tianyi Zhu, Jinfang Xu, Mengjie Wu, Chaoxiang Wang, Lixin Wei, Jia He
Published 2012-01-01

Misuse of Statistical Methods in 10 Leading Chinese Medical Journals in 1998 and 2008

by Shunquan Wu, Zhichao Jin, Xin Wei, Qingbin Gao, Jian Lu, Xiuqiang Ma, Cheng Wu, Qian He, Meijing Wu, Rui Wang, Jinfang Xu, Jia He
Published 2011-01-01

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS

by Chenxin Chen, Ting Chen, Ting Chen, Jizhou Liang, Xiaojing Guo, Jinfang Xu, Yi Zheng, Zhijian Guo, Lijie Chi, Lianhui Wei, Xiao Chen, Xiaofei Ye, Jia He
Published 2021-02-01

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States

by Yinghong Zhai, Yinghong Zhai, Xiaofei Ye, Fangyuan Hu, Jinfang Xu, Xiaojing Guo, Yang Cao, Zhen Lin, Xiang Zhou, Xiang Zhou, Zhijian Guo, Jia He, Jia He
Published 2021-09-01

Knowledge of a cancer diagnosis is a protective factor for the survival of patients with breast cancer: a retrospective cohort study

by Chen He, Wen Xi Zhu, Yunxiang Tang, Yonghai Bai, Zheng Luo, Jinfang Xu, Hao Wang, Shuyu Xu, Jingzhou Xu, Lei Xiao, Ruike Zhang, Yajing Wang, Jing Du, Yujia Huang, Xiaopan Li, Tong Su
Published 2021-06-01